Kyverna Therapeutics, Inc. Common Stock — Institutional Ownership
Which tracked institutions hold KYTX, and how they changed the position last quarter. Latest holdings as of Mar 31, 2026. Source: SEC 13-F filings.
13
Funds holding
$57968992
Total value held
Buying
9 added/new · 3 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Gilead Sciences, Inc. | $35608407 | 4126119 | — | Held |
| 2 | Morgan Stanley | $8434004 | 977289 | -25206 | -2.51% |
| 3 | Blackrock, Inc. | $7569182 | 877078 | +332539 | +61.07% |
| 4 | Goldman Sachs Group Inc | $1837413 | 212910 | +79380 | +59.45% |
| 5 | State Street Corp | $1193529 | 138300 | +47000 | +51.48% |
| 6 | Barclays Plc | $1176916 | 136375 | — | NEW BUY |
| 7 | Wells Fargo & Company/Mn | $704521 | 74949 | +56669 | +310.01% |
| 8 | Northern Trust Corp | $673502 | 78042 | +26470 | +51.33% |
| 9 | Bank Of America Corp /De/ | $480933 | 55728 | +27019 | +94.11% |
| 10 | Raymond James Financial Inc | $138788 | 16082 | -9000 | -35.88% |
| 11 | Citigroup Inc | $115592 | 12297 | +8978 | +270.50% |
| 12 | Royal Bank Of Canada | $23000 | 2548 | — | NEW BUY |
| 13 | Pnc Financial Services Group, Inc. | $13205 | 1530 | -138 | -8.27% |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.